- Molecules
- 35
MedsAcross lists 35 molecules linked to Acute myeloid leukemia, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- PravastatinHMG-CoA Reductase Inhibitor6 presentationsC10AA03
- LenalidomideOrphanThalidomide Analog12 presentations6 brandsL04AX04
- DeferasiroxOrphanIron Chelator24 presentations7 brandsV03AC03
- EverolimusOrphanKinase Inhibitor30 presentations7 brandsL01XE10
- TretinoinOrphanRetinoid24 presentations6 brandsD10AD01
- MethotrexateOrphanFolate Analog Metabolic Inhibitor28 presentations7 brandsL01BA01
- Cyclophosphamide18 presentations1 brandL01AA01
- DoxorubicinOrphanAnthracycline Topoisomerase Inhibitor15 presentations5 brandsL01DB01
- ImatinibOrphanKinase Inhibitor5 presentations5 brandsL01EA01
- FilgrastimOrphanLeukocyte Growth Factor22 presentations15 brandsL03AA02
- BortezomibOrphanProteasome Inhibitor9 presentations6 brandsL01XG01
- NilotinibOrphanKinase Inhibitor10 presentations5 brandsL01EA03
- AzacitidineOrphanNucleoside Metabolic Inhibitor7 presentations8 brandsL01BC07
- EtoposideTopoisomerase Inhibitor8 presentations3 brandsL01CB01
- HydroxyureaOrphanAntimetabolite10 presentations6 brandsL01XX05
- DecitabineOrphanNucleoside Metabolic Inhibitor5 presentationsL01BC08
- CytarabineOrphanNucleoside Metabolic Inhibitor5 presentationsL01BC01
- PlerixaforOrphanHematopoietic Stem Cell Mobilizer2 presentations3 brandsL03AX16
- RuxolitinibOrphanJanus Kinase Inhibitor11 presentations6 brandsD11AH09
- SorafenibOrphanKinase Inhibitor2 presentations3 brandsL01EX02
- IdarubicinOrphanAnthracycline Topoisomerase Inhibitor6 presentations1 brandL01DB06
- ClofarabineOrphanNucleoside Metabolic Inhibitor1 presentation1 brandL01BB06
- BusulfanOrphanAlkylating Drug2 presentations2 brandsL01AB01
- MitoxantroneTopoisomerase Inhibitor3 presentationsL01DB07
- DaunorubicinOrphanAnthracycline Topoisomerase Inhibitor2 presentationsL01DB02
- VenetoclaxOrphanBCL-2 Inhibitor4 presentations2 brandsL01XX52
- PonatinibOrphanKinase Inhibitor4 presentations2 brandsL01EA05
- NivolumabOrphanProgrammed Death Receptor-1 Blocking Antibody4 presentations2 brandsL01FF01
- QuizartinibOrphanKinase Inhibitor2 presentations2 brandsL01EX11
- EnasidenibOrphanIsocitrate Dehydrogenase 2 Inhibitor2 presentations1 brandL01XX59
- GilteritinibOrphan1 presentation2 brandsL01EX13
- MidostaurinOrphanKinase Inhibitor1 presentation1 brandL01XE39
- Gemtuzumab ozogamicinOrphanCD33-directed Immunoconjugate1 presentation2 brandsL01FX02
- ThioguanineAntimetabolite1 presentation1 brandL01BB03
- VorinostatOrphanHistone Deacetylase Inhibitor1 presentation1 brandL01XX38
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Acute myeloid leukemia?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.